Patent details

EP1140941 Title: NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS

Basic Information

Publication number:
EP1140941
PCT Application Number:
PCT/US/1999/030316
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP999674443
PCT Publication Number:
WO/2000/039131
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS
French Title of Invention:
HETEROBICYCLIQUES CONTENANT DE L'AZOTE UTILISES COMME INHIBITEURS DU FACTEUR XA
German Title of Invention:
STICKSTOFFHALTIGE HETEROBICYCLEN ALS FAKTOR-XA-HEMMER
SPC Number:

Dates

Filing date:
17/12/1999
Grant date:
20/10/2004
EP Publication Date:
20/10/2004
PCT Publication Date:
06/07/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/10/2001
EP B1 Publication Date:
20/10/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/12/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/01/2019
 
 

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

History of Owners

From:
31/08/2016
To:
23/01/2019

Name:
BRISTOL-MYERS SQUIBB HOLDINGS IRELAND
Address:
HINTERBERGSTRASSE 16, 6312 STEINHAUSEN, Switzerland (CH)

From:
17/12/1999
To:
30/08/2016

Name:
Bristol-Myers Squibb Pharma Company
Address:
PO Box 4000, Princeton, New Jersey 08443-4000, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
08/12/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
FEVIG John, M.
Address:
United States (US)

2

Name:
PINTO Donald, J., P.
Address:
United States (US)

3

Name:
ROSSI Karen, A.
Address:
United States (US)

4

Name:
LAM Patrick, Yuk, Sun
Address:
United States (US)

5

Name:
PRUITT James, R.
Address:
United States (US)

6

Name:
CACCIOLA Joseph
Address:
United States (US)

7

Name:
CLARK Charles, G.
Address:
United States (US)

Priority

1

Priority Number:
113628 P
Priority Date:
23/12/1998
Priority Country:
United States (US)

2

Priority Number:
127633 P
Priority Date:
02/04/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 487/04;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20190000045A
Date Registered:
23/01/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/11/2018
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
23/01/2019 Request For Change 6
23/01/2019 Outgoing Correspondence 1